Enter your email address:

Delivered by FeedBurner

WHO asks Serum Institute of India for Covishield trial data to begin global supply

Serum Institute of India is one of the manufacturers that has signed
up to supply up to 400 million doses of vaccines to the Covax
Facility. In the first quarter, the company is expected to supply 200
million doses of the AstraZeneca/Oxford vaccine which it has developed
in India and branded as Covishield.



Post a Comment